Lars Nootbaar: Unlocking His Potential After a Challenging Season
Double heel surgery – it's not the ideal start to a player's story, but it's the reality for outfielder Lars Nootbaar. This procedure, addressing bone deformities where the Achilles tendon attaches, is rare in baseball, leaving us with limited precedents to predict his recovery. But here's where it gets intriguing: despite a disappointing 2025 season, Nootbaar's underlying metrics suggest he's a breakout candidate.
Nootbaar, a 28-year-old outfielder, had a tough 2025, posting a .234 batting average and a .686 OPS. However, his advanced stats reveal a different story. With a 96 wRC+ and a 95 OPS+, he demonstrated solid offensive skills. The real concern is his recent surgery, which has no clear baseball recovery timeline. But, with a 94% success rate in a medical study, there's reason for optimism.
Controversy Alert: Is it fair to judge a player's potential based on a single challenging season, especially with a unique medical history? The answer is complex.
Nootbaar's early career showed promise. After a slow start in 2021, he finished strong, and his former hitting coach, Jeff Albert, is now with the Mets. From 2022-2024, Nootbaar maintained above-average defense and a bat 14-23% above average by WRC+. However, injuries limited his playing time, and he never played more than 135 games in a season.
In 2025, Nootbaar's performance dipped, but Statcast data reveals a player with elite potential. His hard-hit rate, walk rate, and exit velocities are all in the top percentiles. The issue? He doesn't pull the ball in the air enough, and his sweet spot percentage is below average. Yet, his overall hitting profile resembles that of Brandon Nimmo at the same age.
The Trade Scenario: The Mets, with their renowned hitting coaches, could be the perfect fit for Nootbaar. If they can unlock his power and improve his pull rate, he might become a Brandon Nimmo-like player with superior defense. Even a repeat of his 2022-2024 performance would significantly boost the Mets' 2026 lineup.
The proposed trade involves the Mets acquiring Nootbaar, while the Cardinals receive Ryan Clifford, a rising outfield/first base prospect, and Simon Juan, an infielder. This trade could provide the Cardinals with outfield depth and a future infielder, while the Mets gain a high-ceiling player. With two years of control, Nootbaar could be a long-term solution for the Mets outfield.
Comment Hook: What's your take on trading for a player coming off surgery? Is Nootbaar a hidden gem or a risky investment? Share your thoughts on this intriguing trade scenario!
